Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2851
New Era Energy & Digital Inc
NUAI
$524M
| $1.65M | ﹤0.01% |
258,948
+232,940
| +896% | +$1.13M |
2026 Q1
1 quarter
|
|
2852
Fate Therapeutics
FATE
$255M
| $1.65M | ﹤0.01% |
610,949
-145,324
| -19% | -$269K |
2017 Q2
36 quarters
|
|
2853
Navigator Holdings
NVGS
$1.47B
| $1.65M | ﹤0.01% |
88,519
+25,135
| +40% | +$545K |
2025 Q2
4 quarters
|
|
2854
Alector
ALEC
$232M
| $1.65M | ﹤0.01% |
818,831
+31,423
| +4% | +$67.3K |
2019 Q1
29 quarters
|
|
2855
RLX Technology
RLX
$2.1B
| $1.64M | ﹤0.01% |
862,910
-2,223
| -0.3% | -$4.62K |
2021 Q2
20 quarters
|
|
2856
Sutro Biopharma
STRO
$220M
| $1.64M | ﹤0.01% |
49,302
+38,725
| +366% | +$1.21M |
2026 Q1
1 quarter
|
|
2857
Ur-Energy
URG
$367M
| $1.63M | ﹤0.01% |
1,201,521
+1,026,342
| +586% | +$1.67M |
2024 Q2
8 quarters
|
|
2858
Qfin Holdings
QFIN
$720M
| $1.63M | ﹤0.01% |
103,321
-261
| -0.3% | -$3.66K |
2021 Q3
19 quarters
|
|
2859
The Magnum Ice Cream Company N.V.
MICC
$10.8B
| $1.62M | ﹤0.01% |
92,983
+23,046
| +33% | +$359K |
2025 Q4
2 quarters
|
|
2860
ClearPoint Neuro
CLPT
$311M
| $1.61M | ﹤0.01% |
89,984
+6,814
| +8% | +$85.1K |
2022 Q3
15 quarters
|
|
2861
Ocugen
OCGN
$321M
| $1.6M | ﹤0.01% |
1,042,537
+830,443
| +392% | +$1.26M |
2021 Q1
21 quarters
|
|
2862
GoodRx Holdings
GDRX
$1.19B
| $1.6M | ﹤0.01% |
553,844
-8,792
| -2% | -$22.3K |
2020 Q4
22 quarters
|
|
2863
ProKidney
PROK
$349M
| $1.59M | ﹤0.01% |
781,729
+153,958
| +25% | +$282K |
2023 Q2
12 quarters
|
|
2864
Defi Technologies
DEFT
$178M
| $1.59M | ﹤0.01% |
3,100,462
-61,970
| -2% | -$42K |
2025 Q2
4 quarters
|
|
2865
XMAX Inc
XMAX
$560M
| $1.59M | ﹤0.01% |
175,166
+149,166
| +574% | +$1.2M |
2026 Q1
1 quarter
|
|
2866
Fulcrum Therapeutics
FULC
$286M
| $1.59M | ﹤0.01% |
433,220
+6,351
| +1% | +$38.6K |
2020 Q1
25 quarters
|
|
2867
James River Group Holdings
JRVR
$169M
| $1.58M | ﹤0.01% |
360,226
+6,303
| +2% | +$31K |
2015 Q1
45 quarters
|
|
2868
Arcturus Therapeutics
ARCT
$358M
| $1.56M | ﹤0.01% |
231,628
+15,128
| +7% | +$119K |
2020 Q2
24 quarters
|
|
2869
Priority Technology Holdings
PRTH
$642M
| $1.55M | ﹤0.01% |
232,500
+15,637
| +7% | +$90.5K |
2019 Q2
28 quarters
|
|
2870
Cooper-Standard Automotive
CPS
$367M
| $1.54M | ﹤0.01% |
57,039
+3,105
| +6% | +$91.5K |
2014 Q2
48 quarters
|
|
2871
Elemental Royalty Corp
ELE
$1.34B
| $1.53M | ﹤0.01% |
+87,617
| New | +$1.54M |
2026 Q2
0 quarters
|
|
2872
InMode
INMD
$823M
| $1.53M | ﹤0.01% |
104,551
+18,221
| +21% | +$254K |
2023 Q2
12 quarters
|
|
2873
Southern California Bancorp
BCAL
$691M
| $1.52M | ﹤0.01% |
73,008
+13,718
| +23% | +$261K |
2024 Q2
8 quarters
|
|
2874
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.72B
| $1.52M | ﹤0.01% |
13,919
-389
| -3% | -$40.1K |
2023 Q3
11 quarters
|
|
2875
Cerence
CRNC
$396M
| $1.52M | ﹤0.01% |
134,053
+12,768
| +11% | +$125K |
2019 Q4
26 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.